Evaluating the PCPT risk calculator in ten international biopsy cohorts: results from the Prostate Biopsy Collaborative Group.
OBJECTIVES: To evaluate the discrimination, calibration, and net benefit performance of the Prostate Cancer Prevention Trial Risk Calculator (PCPTRC) across five European randomized study of screening for prostate cancer (ERSPC), 1 United Kingdom, 1 Austrian, and 3 US biopsy cohorts. METHODS: PCPTRC...
主要な著者: | Ankerst, D, Boeck, A, Freedland, S, Thompson, I, Cronin, A, Roobol, M, Hugosson, J, Stephen Jones, J, Kattan, M, Klein, E, Hamdy, F, Neal, D, Donovan, J, Parekh, D, Klocker, H, Horninger, W, Benchikh, A, Salama, G, Villers, A, Moreira, D, Schröder, F, Lilja, H, Vickers, A |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
2012
|
類似資料
-
Evaluating the Prostate Cancer Prevention Trial High Grade Prostate Cancer Risk Calculator in 10 international biopsy cohorts: results from the Prostate Biopsy Collaborative Group.
著者:: Ankerst, D, 等
出版事項: (2014) -
The relationship between prostate-specific antigen and prostate cancer risk: the Prostate Biopsy Collaborative Group.
著者:: Vickers, A, 等
出版事項: (2010) -
Importance of prostate volume in the European Randomised Study of Screening for Prostate Cancer (ERSPC) risk calculators: results from the prostate biopsy collaborative group.
著者:: Roobol, M, 等
出版事項: (2012) -
A panel of kallikrein markers can predict outcome of prostate biopsy following clinical work-up: an independent validation study from the European Randomized Study of Prostate Cancer screening, France.
著者:: Benchikh, A, 等
出版事項: (2010) -
A panel of kallikrein markers can predict outcome of prostate biopsy following clinical work-up: an independent validation study from the European Randomized Study of Prostate Cancer screening, France
著者:: Villers Arnauld, 等
出版事項: (2010-11-01)